Circulatory mir-34a as an RNA-based, noninvasive biomarker for brain aging

Aging

Volumn 3, Issue 10, 2011, Pages 985-1002

  Li, Xiaoli ^a   Khanna, Amit ^a   Li, Na ^a   Wang, Eugenia ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Aging; Bcl2; Biomarker; Micrornas; mir 34a, and mir 196a; Sirt1

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MIRN34 MICRORNA, MOUSE; PROTEIN BCL 2; PROTEIN P53; SIRT1 PROTEIN, MOUSE; SIRTUIN 1;

AGING; ANIMAL; ARTICLE; BLOOD; BRAIN; C57BL MOUSE; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

AGING; ANIMALS; BIOLOGICAL MARKERS; BRAIN; MICE; MICE, INBRED C57BL; MICRORNAS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80855165230     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100371     Document Type: Article

References (48)

1. Miller RA. The aging immune system: primer and prospectus. Science. 1996; 273: 70-74.
2. Esiri MM. Ageing and the brain. J Pathol. 2007; 211: 181-187.
3. Haigis MC, Yankner BA. The aging stress response. Mol Cell. 2010; 40: 333-344.
4. Carallo C, Irace C, De Franceschi MS, Coppoletta F, Tiriolo R, Scicchitano C, Scavelli F, Gnasso A. The effect of aging on blood and plasma viscosity. An 11.6 years follow-up study. Clin Hemorheol Microcirc. 2011; 47: 67-74.
5. Sprott RL. Biomarkers of aging. Exp Gerontol. 1988; 23: 1-3.
6. Miura Y, Kano M, Yamada M, Nishine T, Urano S, Suzuki S, Endo T, Toda T. Proteomic study on X-irradiation-responsive proteins and ageing: search for responsible proteins for radiation adaptive response. J Biochem. 2007; 142: 145-155.
7. Sonntag WE, Ramsey M, Carter CS. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev. 2005; 4: 195-212.
8. Yang H, Lyutvinskiy Y, Soininen H, Zubarev RA. Alzheimer's Disease and Mild Cognitive Impairment are associated with elevated levels of isoaspartyl residues in blood plasma proteins. J Alzheimers Dis. 2011. doi: 10.3233/JAD-2011-110626.
9. Grolleau-Julius A, Ray D, Yung RL. The role of epigenetics in aging and autoimmunity. Clin Rev Allergy Immunol. 2010; 39: 42-50.
10. Liang R, Bates DJ, Wang E. Epigenetic control of MicroRNA expression and aging. Curr Genomics. 2009; 10: 184-193.
11. Kato M, Slack FJ. MicroRNAs: small molecules with big roles - C. elegans to human cancer. Biol Cell. 2008; 100: 71-81.
12. Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science. 2005; 310: 1954-1957.
13. Maes OC, Chertkow HM, Wang E, Schipper HM. MicroRNA: Implications for Alzheimer Disease and other human CNS disorders. Curr Genomics. 2009; 10: 154-168.
14. Bates DJ, Li N, Liang R, Sarojini H, An J, Masternak MM, Bartke A, Wang E. MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging. Aging Cell. 2010; 9: 1-18.
15. Li N, Bates DJ, An J, Terry DA, Wang E. Up-regulation of key microRNAs, and inverse down-regulation of their predicted oxidative phosphorylation target genes, during aging in mouse brain. Neurobiol Aging. 2011; 32: 944-955.
16. Li N, Muthusamy S, Liang R, Sarojini H, Wang E. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech Ageing Dev. 2011; 132: 75-85.
17. Khanna A, Muthusamy S, Liang R, Sarojini H, Wang E. Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice. Aging (Albany NY). 2011; 3: 223-236.
18. Maes OC, Schipper HM, Chertkow HM, Wang E. Methodology for discovery of Alzheimer's disease blood-based biomarkers. J Gerontol A Biol Sci Med Sci. 2009; 64: 636-645.
19. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513-10518.
20. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008; 3: e3694.
21. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110: 13-21.
22. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabro E, Croce CM, Pastorino U, Sozzi C. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A. 2011; 108: 3713-3718.
23. Benner SA. Extracellular 'communicator RNA'. FEBS Lett. 1988; 233: 225-228.
24. Tsang J, Zhu J, van Oudenaarden A. MicroRNA-mediated feedback and feed forward loops are recurrent network motifs in mammals. Mol Cell. 2007; 26: 753-767.
25. Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Bjorkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet. 2011; 20:2225-2237.
26. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H, Verdin E. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY). 2010; 2:415-431.
27. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hebuterne X, Harel-Bellan A, Mograbi B, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM- dependent xenophagy in Crohn's disease. Nat Genet. 2011; 43: 242-245.
28. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A. 2008; 105: 13421-13426.
29. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007; 26: 745-52.
30. Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics. 2008; 8: 4083-4099.
31. Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R. MicroRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell cycle. 2010; 9: 1031-1036.
32. Hermeking H. MiR-34a and p53. Cell Cycle. 2009; 8: 1308.
33. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle. 2009; 8: 712-715.
34. Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvari M, Piper MD, Hoddinott M, Sutphin GL, Leko V, McElwee JJ, Vazquez-Manrique RP, Orfila AM, Ackerman D, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature. 2011; 477: 482-485.
35. Herranz D, Serrano M. Impact of Sirt1 on mammalian aging. Aging (Albany NY). 2010; 2: 315-316.
36. Lee J, Kemper JK. Controlling SIRT1 expression by microRNAs in health and metabolic disease. Aging (Albany NY). 2010; 2: 527-534.
37. Ramadori G, Coppari R. Does hypothalamic SIRT1 regulate aging? Aging (Albany NY). 2011; 3: 325-328.
38. Poyurovsky MV, Prives C. P53 and aging: A fresh look at an old paradigm. Aging (Albany NY). 2010; 2: 380-382.
39. Biteau B, Jasper H. It's all about balance: p53 and aging. Aging (Albany NY). 2009; 1: 884-886.
40. Roemer K. Are the conspicuous interdependences of fecundity, longevity and cognitive abilities in humans caused in part by p53? Cell Cycle. 2010; 9: 3438-3441.
41. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, Yamada T, Kikuchi H, Taniwaki T, Murai H, Ikezoe K, Furuya H, Kawarabayashi T, et al. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J. 19: 255-257.
42. Schipper HM, Maes OC, Chertkow HM, Wang E. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio. 2007; 1: 263-274.
43. Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement. 2011; 7: 402-411.
44. Griffin WS, Liu L, Li Y, Mrak RE, Barger SW. Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation. 2006; 3: 5.
45. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier F, Lithgow GJ, Campisi J. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY). 2009; 1: 402-411.
46. Delay C, Hébert SS. MicroRNAs and Alzheimer's disease mouse models: Current insights and future research avenues. Int J Alzheimers Dis. 2011; 2011: 894938.
47. Provost P. Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases. Aging (Albany NY). 2010; 2: 166-169.
48. Pendyala G, Trauger SA, Siuzdak G, Fox HS. Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. J Proteome Res. 2010; 9, 352-358.